Peritoneal cytology: A risk factor of recurrence for non-endometrioid endometrial cancer

Gynecologic Oncology

Volumn 134, Issue 2, 2014, Pages 293-296

  Han, Kyung Hee ^a   Park, Noh Hyun ^a   Kim, Hee Seung ^a   Chung, Hyun Hoon ^a   Kim, Jae Weon ^a   Song, Yong Sang ^a  

^a Seoul National University   (South Korea)

Author keywords

Cytology; Endometrial neoplasms; Prognosis; Recurrence; Survival

Indexed keywords

CYTOLOGY; ENDOMETRIAL NEOPLASMS; PROGNOSIS; RECURRENCE; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERITONEUM; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84905581356     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.05.010     Document Type: Article

References (23)

1. G. Emons, G. Fleckenstein, B. Hinney, A. Huschmand, and W. Heyl Hormonal interactions in endometrial cancer Endocr Relat Cancer 7 2000 227 242
2. A. Mariani, M.J. Webb, G.L. Keeney, G. Aletti, and K.C. Podratz Endometrial cancer: predictors of peritoneal failure Gynecol Oncol 89 2003 236 242
3. E. Kuhn, R.C. Wu, B. Guan, G. Wu, J. Zhang, and Y. Wang et al. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses J Natl Cancer Inst 104 2012 1503 1513
4. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1983 10 17
5. S. Vance, R. Yechieli, C. Cogan, R. Hanna, A. Munkarah, and M.A. Elshaikh The prognostic significance of age in surgically staged patients with type II endometrial carcinoma Gynecol Oncol 126 2012 16 19
6. F.D. Cirisano Jr., S.J. Robboy, R.K. Dodge, R.C. Bentley, H.R. Krigman, and I.S. Synan et al. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma Gynecol Oncol 74 1999 385 394
7. A. Mendivil, K.M. Schuler, and P.A. Gehrig Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes Cancer Control 16 2009 46 52
8. T.O. Wilson, K.C. Podratz, T.A. Gaffey, G.D. Malkasian Jr., P.C. O'Brien, and J.M. Naessens Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma Am J Obstet Gynecol 162 1990 418 423 [discussion 23-6]
9. F. Musa, M. Huang, B. Adams, E. Pirog, and K. Holcomb Mucinous histology is a risk factor for nodal metastases in endometrial cancer Gynecol Oncol 125 2012 541 545
10. C.L. Kosary FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina Semin Surg Oncol 10 1994 31 46
11. D. Faratian, A. Stillie, R.M. Busby-Earle, V.J. Cowie, and H. Monaghan A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome Int J Gynecol Cancer 16 2006 972 978
12. I. Mylonas, and C. Schindlbeck Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma Arch Gynecol Obstet 285 2012 207 214
13. A. Mariani, S.C. Dowdy, and K.C. Podratz New surgical staging of endometrial cancer: 20 years later Int J Gynaecol Obstet 105 2009 110 111
14. S.L. Wethington, N.I. Barrena Medel, J.D. Wright, and T.J. Herzog Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: unraveling a mystery Gynecol Oncol 115 2009 18 25
15. G. Garg, F. Gao, J.D. Wright, A.R. Hagemann, I. Zighelboim, and D.G. Mutch et al. The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer Int J Gynecol Cancer 23 2013 90 97
16. S.A. Milgrom, M.A. Kollmeier, N.R. Abu-Rustum, V. Makker, G.J. Gardner, and R.R. Barakat et al. Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer Gynecol Oncol 130 2013 49 53
17. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 1987 2035 2041
18. S. Greggi, G. Mangili, C. Scaffa, F. Scala, S. Losito, and F. Iodice et al. Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study Int J Gynecol Cancer 21 2011 661 667
19. B.A. Goff, D. Kato, R.A. Schmidt, M. Ek, J.A. Ferry, and H.G. Muntz et al. Uterine papillary serous carcinoma: patterns of metastatic spread Gynecol Oncol 54 1994 264 268
20. R.A. Soslow, S.L. Wethington, M. Cesari, D. Chiappetta, N. Olvera, and J. Shia et al. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma Am J Surg Pathol 36 2012 1771 1781
21. A.A. Martinez, S. Weiner, K. Podratz, A.R. Armin, J.S. Stromberg, and R. Stanhope et al. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation Gynecol Oncol 90 2003 537 546
22. L.J. Havrilesky, J.M. Cragun, B. Calingaert, A. Alvarez Secord, F.A. Valea, and D.L. Clarke-Pearson et al. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer Gynecol Oncol 104 2007 401 405
23. A.N. Fader, D. Starks, P.A. Gehrig, A.A. Secord, H.E. Frasure, and D.M. O'Malley et al. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC) Gynecol Oncol 115 2009 244 248